Correction: Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial

Affiliations

• ¹ Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
• ² Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
• ³ Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
• ⁴ Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
• ⁵ Splice Therapeutics, 20271 Goldenrod Lane, Lab 2071, Germantown, MD, 20876, USA.
• ⁶ Myriad Neuroscience, Mason, OH, USA.
• ⁷ Myriad Genetics, Salt Lake City, UT, USA.
• ⁸ Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
• ⁹ Department of Psychiatry, UC San Diego, San Diego, CA, USA.
• ¹⁰ Mood Disorders Treatment and Research Centre and Women's Health Concerns Clinic, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada.
• ¹¹ Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada.
• ¹² Department of Health Research Methods, Evidence and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Canada.
• ¹³ Program for Health System and Technology Evaluation, Ted Rogers Centre for Heart Research at Peter Munk Cardiac Centre, Toronto General Hospital Research Institute (TGHRI), Hamilton, Canada.
• ¹⁴ Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network (UHN), Hamilton, Canada.
• ¹⁵ Department of Health Research Methods, Evidence, and Impact (HEI), Faculty of Health Science, McMaster University, Hamilton, ON, Canada.
• ¹⁶ Programs for Assessment of Technology in Health (PATH), The Research Institute of St. Joe's Hamilton, St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada.
• ¹⁷ Center for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada.
• ¹⁸ Family Medicine, McMaster University, Hamilton, ON, Canada.
• ¹⁹ Chatham-Kent Health Alliance, Chatham, ON, Canada.
• ²⁰ Thornhill Medical Center, Toronto, ON, Canada.
• ²¹ Department of Psychiatry, University of Calgary, Hotchkiss Brain Institute, an Institute of the Cumming School of Medicine, Calgary, AB, Canada.
• ²² Hôpital Montfort, Ottawa, ON, Canada.
• ²³ Department of Psychiatry, University of Ottawa, Ottawa, ON, Canada.
• ²⁴ Department of Psychiatry, Western University, London, ON, Canada.
• ²⁵ Department of Psychiatry, Geriatric Psychiatry and Neurosciences, Western University, London, ON, Canada.
• ²⁶ Integrative Psychiatry Lab, Parkwood Institute of Mental Health, London, ON, Canada.
• ²⁷ Milestone Research, London, ON, Canada.
• ²⁸ Canadian Phase Onward Inc., Polyclinic Family and Specialty Medicine Facility, Polyclinic Family Health Group, Toronto, ON, Canada.
• ²⁹ Hamilton Community Health Centre, Hamilton, ON, Canada.
• ³⁰ Tanenbaum Centre for Pharmacogenetics, Neurogenetics Section, Molecular Brain Sciences Research Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada. jim.kennedy@camh.ca.
• ³¹ Department of Psychiatry, University of Toronto, Toronto, ON, Canada. jim.kennedy@camh.ca.
• ³² Institute of Medical Science, University of Toronto, Toronto, ON, Canada. jim.kennedy@camh.ca.